Last edition
News about "Sygnature Discovery "
Sygnature Discovery Partners with DaltonTx to Advance AI-Driven Drug Discovery
Sygnature Discovery has partnered with DaltonTx to enhance Artificial Intelligence (AI)-enabled drug discovery capabilities, accelerating medicinal chemistry decision-making while maintaining robust data security standards to support faster and more efficient therapeutic research and development.
Sygnature Discovery | 05/06/2026 | By News Bureau | 126
Sygnature Discovery Appoints New Chief Scientific Officer
Sygnature Discovery has appointed Dr. David Witty as Chief Scientific Officer (CSO) to its leadership team.
Sygnature Discovery | 24/04/2024 | By Aishwarya | 918
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy